![](/img/cover-not-exists.png)
The use of polyethylene glycol-modified interleukin-2 (PEG-IL-2) in the treatment of patients with metastatic renal cell carcinoma and melanoma
James C. Yang, Suzanne L. Topalian, Douglas J. Schwartzentruber, David R. Parkinson, Francesco M. Marincola, Jeffrey. S. Weber, Claudia A. Seipp, Donald E. White, Steven A. RosenbergVolume:
76
Year:
1995
Language:
english
Pages:
8
DOI:
10.1002/1097-0142(19950815)76:43.0.co;2-m
File:
PDF, 707 KB
english, 1995